BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 19460787)

  • 1. Effects of a leukotriene B4 receptor antagonist on bleomycin-induced pulmonary fibrosis.
    Izumo T; Kondo M; Nagai A
    Eur Respir J; 2009 Dec; 34(6):1444-51. PubMed ID: 19460787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cysteinyl-leukotriene 1 receptor antagonist attenuates bleomycin-induced pulmonary fibrosis in mice.
    Izumo T; Kondo M; Nagai A
    Life Sci; 2007 Apr; 80(20):1882-6. PubMed ID: 17397875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VEGFR-2 antagonist SU5416 attenuates bleomycin-induced pulmonary fibrosis in mice.
    Ou XM; Li WC; Liu DS; Li YP; Wen FQ; Feng YL; Zhang SF; Huang XY; Wang T; Wang K; Wang X; Chen L
    Int Immunopharmacol; 2009 Jan; 9(1):70-9. PubMed ID: 18976720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of montelukast, a cysteinyl-leukotriene type 1 receptor antagonist, on the pathogenesis of bleomycin-induced pulmonary fibrosis in mice.
    Shimbori C; Shiota N; Okunishi H
    Eur J Pharmacol; 2011 Jan; 650(1):424-30. PubMed ID: 21034736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydrogen sulfide protects against bleomycin-induced pulmonary fibrosis in rats by inhibiting NF-κB expression and regulating Th1/Th2 balance.
    Cao H; Zhou X; Zhang J; Huang X; Zhai Y; Zhang X; Chu L
    Toxicol Lett; 2014 Jan; 224(3):387-94. PubMed ID: 24269241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukotriene C4 aggravates bleomycin-induced pulmonary fibrosis in mice.
    Hirata H; Arima M; Fukushima Y; Sugiyama K; Tokuhisa T; Fukuda T
    Respirology; 2013 May; 18(4):674-81. PubMed ID: 23432979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Taurine and niacin block lung injury and fibrosis by down-regulating bleomycin-induced activation of transcription nuclear factor-kappaB in mice.
    Gurujeyalakshmi G; Wang Y; Giri SN
    J Pharmacol Exp Ther; 2000 Apr; 293(1):82-90. PubMed ID: 10734156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Berberine attenuates bleomycin induced pulmonary toxicity and fibrosis via suppressing NF-κB dependant TGF-β activation: a biphasic experimental study.
    Chitra P; Saiprasad G; Manikandan R; Sudhandiran G
    Toxicol Lett; 2013 May; 219(2):178-93. PubMed ID: 23523906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of antisense oligonucleotide to nuclear factor-kappaB on the development of bleomycin-induced pulmonary fibrosis and IL-4 expression therein: experiment with mice].
    Zhang XY; Zhou Y; Liu WQ; Zhao L; Li SQ
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):195-9. PubMed ID: 17425852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-{beta} inhibits bleomycin-induced lung fibrosis by decreasing transforming growth factor-{beta} and thrombospondin.
    Azuma A; Li YJ; Abe S; Usuki J; Matsuda K; Henmi S; Miyauchi Y; Ueda K; Izawa A; Sone S; Hashimoto S; Kudoh S
    Am J Respir Cell Mol Biol; 2005 Feb; 32(2):93-8. PubMed ID: 15557019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucagon like peptide-1 attenuates bleomycin-induced pulmonary fibrosis, involving the inactivation of NF-κB in mice.
    Gou S; Zhu T; Wang W; Xiao M; Wang XC; Chen ZH
    Int Immunopharmacol; 2014 Oct; 22(2):498-504. PubMed ID: 25111852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of cordyceps sinensi on bleomycin-induced pulmonary fibrosis in mice].
    Wang SJ; Bai W; Wang CL; Dai Z
    Zhongguo Zhong Yao Za Zhi; 2007 Dec; 32(24):2623-7. PubMed ID: 18338602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of pravastatin on bleomycin-induced acute lung injury and pulmonary fibrosis.
    Kim JW; Rhee CK; Kim TJ; Kim YH; Lee SH; Yoon HK; Kim SC; Lee SY; Kwon SS; Kim KH; Kim YK
    Clin Exp Pharmacol Physiol; 2010 Nov; 37(11):1055-63. PubMed ID: 20659133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the chemokine receptor CXCR2 in bleomycin-induced pulmonary inflammation and fibrosis.
    Russo RC; Guabiraba R; Garcia CC; Barcelos LS; Roffê E; Souza AL; Amaral FA; Cisalpino D; Cassali GD; Doni A; Bertini R; Teixeira MM
    Am J Respir Cell Mol Biol; 2009 Apr; 40(4):410-21. PubMed ID: 18836137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The pivotal role of CXCR3 in the pathogenesis of bleomycin-induced pulmonary fibrosis].
    Gao JM; Lu B
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Jan; 28(1):28-32. PubMed ID: 15774188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of andrographolide on the concentration of cytokines in BALF and the expressions of type I and III collagen mRNA in lung tissue in bleomycin-induced rat pulmonary fibrosis].
    Zhu HL; Huang CL; Wang WJ; Zhan XQ; Fan XM
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jul; 27(7):725-9. PubMed ID: 21722520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-10 inhibits inflammation but does not affect fibrosis in the pulmonary response to bleomycin.
    Kradin RL; Sakamoto H; Jain F; Zhao LH; Hymowitz G; Preffer F
    Exp Mol Pathol; 2004 Jun; 76(3):205-11. PubMed ID: 15126102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of curcumin on bleomycin-induced pulmonary fibrosis in rats].
    Zhang DP; Qiu H; Zhuang Y; Meng FQ
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Mar; 30(3):197-201. PubMed ID: 17572999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (5R)-5-hydroxytriptolide (LLDT-8) protects against bleomycin-induced lung fibrosis in mice.
    Ren YX; Zhou R; Tang W; Wang WH; Li YC; Yang YF; Zuo JP
    Acta Pharmacol Sin; 2007 Apr; 28(4):518-25. PubMed ID: 17376291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of pulmonary fibrosis by the chemokine IP-10/CXCL10.
    Tager AM; Kradin RL; LaCamera P; Bercury SD; Campanella GS; Leary CP; Polosukhin V; Zhao LH; Sakamoto H; Blackwell TS; Luster AD
    Am J Respir Cell Mol Biol; 2004 Oct; 31(4):395-404. PubMed ID: 15205180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.